AK Medical Holdings Limited (1789) Announces Multiple Tender Wins and New Robotic Systems

Bulletin Express
Yesterday

AK Medical Holdings Limited (1789) disclosed that Beijing Yidian Lingdong Technology Co., Ltd., a wholly-owned subsidiary, recently secured the orthopedic hip surgery navigation system tender from The First Affiliated Hospital, Zhejiang University School of Medicine. According to the announcement dated 9 February 2026, the group also obtained several additional tenders from December 2024 to January 2026, including projects for Shandong Provincial Hospital, Qingdao Hospital of Traditional Chinese Medicine (Qingdao Haici Hospital), Peking University Third Hospital, and a hospital in Shandong. Contract sums ranged from RMB3.98 million to RMB8.3 million, with some announced amounts remaining unpublished.

AK Medical Holdings Limited highlighted its K3 Robotic System, which features a compact robotic arm and provides support from preoperative planning to intraoperative assistance. The K3+ Robotic System, approved for marketing on 15 January 2026, can perform revision surgeries for hip, knee, and unicompartmental knee procedures. The group also presented its Visual Treatment Solution Visual Intelligent Assistance System, offering real-time visual tracking and acetabular prosthesis implantation guidance for total hip replacement arthroplasty.

In parallel, AK Medical Holdings Limited reported progress in its digital orthopedics full-process solution, covering 3D modeling, surgical planning, 3D printing, and customized surgical tools and prostheses. A provincial key hospital in Shandong began charging fees for digital orthopedics services in January 2026. Additionally, the group entered a strategic cooperation agreement with a provincial key hospital in Henan in January 2026.

Shareholders and potential investors are reminded to exercise caution when trading the company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10